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Abstract The Dlx3 homeodomain gene is expressed in termin-
ally differentiated murine epidermal cells. As demonstrated for
differentiation-specific granular markers, Dlx3 is activated in
primary mouse keratinocytes cultured in vitro by increasing the
level of the extracellular Ca2+. This activation is mediated
through a protein kinase C-dependent (PKC) pathway. In this
study, we investigated whether PKC can modulate the activity of
murine Dlx3 protein. Using in vitro kinase assays, we show that
PKC enzymes phosphorylate the Dlx3 protein. Using keratino-
cyte nuclear extracts for the kinase reaction, we determined that
Dlx3 protein is phosphorylated, and the phosphorylation is
inhibited by the PKC-specific inhibitor GF109203X, suggesting
that Dlx3 is phosphorylated by PKC in vivo. Of the PKC
isoforms present in the epidermis, we tested K, N, O and j. Dlx3 is
primarily phosphorylated by PKCK. By deletion and mutational
analysis, we show that the serine residue S138, located in the
homeodomain of Dlx3 protein, was specifically phosphorylated
by PKC. The phosphorylation of purified Dlx3 proteins by PKC
partially inhibited formation of complexes between Dlx3 protein
and DNA. These results suggest that Dlx3 protein can be directly
phosphorylated by PKC and this affects the DNA binding
activity of Dlx3. ß 2001 Published by Elsevier Science B.V.
on behalf of the Federation of European Biochemical Societies.
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1. Introduction
The strati¢ed epidermis is characterized by outward migra-
tion of keratinocytes from the proliferative basal compart-
ment to the upper, terminally di¡erentiated corni¢ed layer
of the skin. The di¡erentiation process is associated with the
sequential induction and repression of structural and enzy-
matic strati¢cation-speci¢c markers [1]. In primary basal
mouse keratinocytes cultivated in vitro, this process can be
induced by increasing by Ca2 concentration in the culture
medium [2]. Activation of protein kinase C (PKC) has been
shown to be essential for expression of the late di¡erentiation
markers loricrin and pro¢laggrin [3].
Dlx3, a murine ortholog of the Drosophila Distal-less ho-
meodomain protein [4], is a member of the Dlx vertebrate
family. Dlx3 is a transcriptional activator with an AT-rich
DNA binding site [5], which is primarily expressed in the
di¡erentiated granular layer of the epidermis and in the hair
matrix cells of the hair follicle [6]. Transgenic temporal and
spatial mis-expression of Dlx3 in the basal layer caused an
abnormal skin phenotype, characterized by cessation of pro-
liferation and premature di¡erentiation of the basal cells
judged by the upregulation of expression of late di¡erentiation
markers [6]. Disruption of the DLX3 coding sequence has
been associated with the autosomal dominant human tricho-
dento-osseous syndrome, characterized by defects in ectoder-
mal derivatives such as hair and teeth, and craniofacial bone
abnormalities [7]. The expression of Dlx3, as for the di¡er-
entiation markers, is activated by Ca2 in keratinocytes in-
duced to di¡erentiate in culture [8]. These data support a role
for Dlx3 as a determinant factor in the activation of expres-
sion of granular markers during the terminal di¡erentiation of
keratinocytes.
PKC consists of a multigene family of closely related serine-
threonine kinase isozymes that have been implicated in nu-
merous biological processes including di¡erentiation [9]. The
K, N, O, R, and j isoforms of PKC are expressed in murine
keratinocytes [10,11]. Ca2 changes the subcellular distribu-
tion of PKC in vitro [11,12], and the calcium-induced expres-
sion of genes for the epidermal di¡erentiation markers trans-
glutaminase, loricrin, and pro¢laggrin is dependent upon
PKC activation [3]. The importance of PKC in keratinocyte
di¡erentiation is substantiated by the fact that PKC activators
such as 12-O-tetradecanoylphorbol-13-acetate also induce late
di¡erentiation marker expression in vitro in the absence of
changes in extracellular Ca2 levels [13]. The AP-1 transcrip-
tion factor is known to be a nuclear target of PKC signal
transduction [14]. The transcription of involucrin, one of the
keratinocyte terminal di¡erentiation marker, is activated by
the PKC signaling pathway through AP-1 signal transduction
[15].
We have been studying the regulation of Dlx3 transcription
during keratinocyte di¡erentiation [16]. Since epidermal di¡er-
entiation is dependent on PKC activation, and Dlx3 is
thought to be involved in this process, we examined whether
PKC phosphorylates Dlx3 protein and if these posttransla-
tional modi¢cations modulate its function.
2. Materials and methods
2.1. Plasmid construction
To express the murine Dlx3 protein in bacteria, the cDNA of the
Dlx3 gene was inserted in the pET28a Escherichia coli expression
vector (Invitrogen), at BglII and XhoI sites. Each deletion mutant
DNA fragment of Dlx3 was constructed by PCR and inserted into
the BglII and XhoI site of pET28a. The following primers were used:
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pET124^287 (5P-CGCAGATCTGGCAAGCCCAAAAAGGTCCG-
AAAGCCGCG-3P and 5P-CCGCTCGAGTCAGTACACAGCCCC-
AGGGTTAGG-3P), pET 130^188 (5P-GGAAGATCTCGAAAG-
CCGCGAACGATCTACT-3P and 5P-CCGCTCGAGATAGAGCT-
TTTTGAACTTGGAGCGG-3P), pET 195^287 (5P-GGAAGATCT-
CTGGAACACAGCCCCAACAACAGT-3P and 5P-CCGCTCGA-
GTCAGTACACAGCCCCAGGGTTAGG-3P). Amino acid muta-
tions in the Dlx3 protein were created by replacing the codons for
Ser137, Ser138, Ser182 and Thr134 with codons for Ala by site-directed
mutagenesis (QuickChange, Stratagene). All mutations were con-
¢rmed by DNA sequencing.
2.2. Phosphorylation assays
In vitro phosphorylation reactions were performed as follows: ap-
proximately 100 ng of each puri¢ed bacterial protein was incubated
with 25 ng (0.04 U) of PKC (Promega) at 37‡C for 30 min in assay
bu¡er (40 mM Tris^HCl, pH 7.4, 10 mM MgCl2, bovine serum albu-
min at 100 Wg/ml, 0.4 mM CaCl2, 100 Wg/ml phosphatidylserine) and
0.1 Wl of [Q-32p]ATP (4500 Ci/mmol; NEN Dupont). Reactions were
terminated by adding SDS loading bu¡er and boiling for 3 min.
Proteins were subjected to SDS^PAGE and transferred onto polyvi-
nylidene £uoride (PVDF) membrane. The transferred membrane was
analyzed by Western blotting with T7 antigen Ab (Invitrogen) and
exposed to X-ray ¢lm overnight.
For the kinase assays with nuclear extract and PKC-speci¢c inhib-
itor, 100 ng of puri¢ed Dlx3 protein was incubated with 5 Wg of
primary keratinocyte nuclear extract and the PKC inhibitor
GF109203X (GF, bisindolylmaleimide I, Alexis) or PKA inhibitor
H-89 (Alexis), in the same assay bu¡er described above and immuno-
precipitated with anti-His antibody (Santa Cruz). The samples were
then analyzed by Western blotting and exposed to X-ray ¢lm.
2.3. Preparation of bacterial fusion proteins
His-tagged fusion proteins were prepared as described by Novagen.
Brie£y, 100 ml of cultured E. coli BL21 (DE3) (Novagen) was induced
with 1 mM isopropyl-L-D-thiogalactopyranoside for 3 h at 37‡C. His-
tagged proteins were obtained using His-Bind resin according to No-
vagen. GST-tagged fusion proteins were prepared according to the
manufacturer’s guide using glutathione-Sepharose 4B (Pharmacia).
2.4. Preparation of nuclear extracts and gel retardation assays
Primary mouse keratinocytes were isolated from BALB/c newborn
mouse skins and grown in Eagle’s minimal essential medium lacking
Ca2, with 8% Chelex-treated fetal bovine serum. Nuclear extracts
were prepared from primary mouse keratinocyte cultures as described
by Andreas and Faller [17]. Gel retardation analysis was carried out
according to Park and Morasso [16], using 32P-end-labeled Dlx3 bind-
ing consensus sequence (5P-CGGATCCATAATTGCTGGAATTCC-
3P) oligonucleotide [5].
2.5. Mass spectrometry
Stained bands after SDS^PAGE of phosphorylated and non-phos-
phorylated homeodomain of Dlx3 were excised and broken into pieces
with a microhomogenizer in 0.2-ml PCR plastic tubes. Gel pieces were
sequentially extracted with 2U100 Wl 50% acetonitrile in 25 mM
NH4CO3 pH 8.1, 100% acetonitrile and dried under vacuum. The
gels were allowed to swell in 20 Wg/ml sequencing grade modi¢ed
trypsin (Promega) in 25 mM NH4CO3 pH 8.1 and digested overnight
at 37‡C. Protein fragments were extracted with 100 Wl 60% acetoni-
trile, 0.5% tri£uoroacetic acid (TFA), the extracts were concentrated
6^8-fold in vacuum and were freed from salts on a C18 zip-tip (Milli-
pore). The peptide mixture was mixed 1:1 with a freshly prepared
matrix solution (saturated K-cyano-4-hydroxycinnamic acid in 50%
acetonitrile, 0.3% TFA) and spotted on sample plates.
Mass spectra were collected on a Voyager DE-PRO MALDI-TOF
mass spectrometer in the delayed extraction mode. Sixty-four to 128
scans from a nitrogen laser (337 nm) were averaged in each recorded
spectrum.
3. Results
Expressed Dlx3 protein was immunoprecipitated with anti-
His antibody and protein A agarose, and incubated with a
nuclear extract of mouse keratinocytes in assay bu¡er, with
or without 1 WM or 10 WM of PKC-speci¢c inhibitor GF or
10 WM of PKA-speci¢c inhibitor H-89, as a control. As shown
in Fig. 1A, Dlx3 protein was speci¢cally phosphorylated in
nuclear extract, and this phosphorylation was inhibited by
GF, but not by H-89. This result suggested that the Dlx3
protein could be phosphorylated by PKC in vivo. Further-
more, we show that puri¢ed Dlx3 protein is phosphorylated
Fig. 1. Dlx3 is phosphorylated by PKC. A: Bacterially expressed
Dlx was immunoprecipitated with anti-His antibody and incubated
with 5 Wg of nuclear extract of mouse keratinocytes. The PKC in-
hibitor GF was added in the reaction at 1 WM (lane 3) and 10 WM
concentrations (lane 4). The PKA inhibitor H-89 was also added in
the reaction (lane 5). Samples were subjected to SDS^PAGE, and
transferred to a PVDF membrane. The amount of Dlx3 protein in
each reaction was determined by Western blotting analysis (lower
panel) using the T7 tag antibody (Novagen). The membrane was ex-
posed to X-ray ¢lm for autoradiography. Arrows indicate the Dlx3
protein. B: Dlx3 protein (100 ng) was incubated for 30 min at 37‡C
in the presence or absence of PKC and Q-ATP. Dlx3 protein was
also incubated with casein kinase II (CKII). Samples were then sep-
arated by electrophoresis on SDS^PAGE. The amount of Dlx3 pro-
tein used in each reaction was determined by Western blot analysis
(lower panel). C: Dlx3 protein was incubated in the presence or ab-
sence of PKC isoforms K, N, O, j (Calbiochem) in the presence of
Q-ATP. The amount of Dlx3 protein used in each reaction is shown
in the Western blot in the lower panel using the T7 tag antibody
(Novagen). The bottom panel shows the autophosphorylation of
each PKC isoform, demonstrating the speci¢c activity of each PKC
isoform.
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by PKC in vitro, by performing kinase reaction with puri¢ed
PKC (Promega). PKC from Promega consists primarily of the
K and L isozymes, and is at least 90% pure PKCK by SDS^
PAGE. Casein kinase II (CKII) was also tested for the ability
to phosphorylate Dlx3. As shown in Fig. 1B, Dlx3 was spe-
ci¢cally phosphorylated by PKC and no detectable phosphor-
ylation was observed in assays with CKII.
Several subtypes of the PKC family (K, N, O, R, and j iso-
forms) are expressed in keratinocytes. To examine which PKC
subtype was able to phosphorylate Dlx3, we performed in
vitro kinase assays with the commercially available PKCK,
PKCN, PKCO, and PKCj (Calbiochem). Dlx3 protein was
strongly phosphorylated by PKCK, to a much lesser extent
by PKCN and PKCO and not by PKCj (Fig. 1C). The speci¢c
activity of each PKC isoform was not much di¡erent from
each other, as is shown by autophosphorylation of each PKC
isoform in Fig. 1C, bottom panel. These results showed that
in vitro, the Ca2-dependent PKCK was the most e¡ective
kinase of Dlx3. Since Dlx3 localizes to the nucleus in di¡er-
entiated keratinocytes [18], we corroborated the presence of
the PKCK isoform in the nucleus, as has been shown in
NIH3T3 upon treatment with phorbol ester [19], by Western
blot analysis of nuclear extracts of suprabasal epidermal cells
(data not shown).
To determine the phosphorylation site(s) within the Dlx3
protein, we incubated PKC with: the full-length Dlx3 protein
(pET 1^287), amino-terminal deletion mutant (pET 124^287),
homeodomain (pET 130^188), and carboxy-terminal (pET
194^287) (Fig. 2A). As shown in Fig. 2B, PKC phosphorylat-
ed the amino-terminal deletion mutant (124^287) and homeo-
domain of Dlx3 protein (130^188). PKC weakly phosphory-
lated the full-length Dlx3, but not the carboxy-terminal. The
result delineated the phosphorylation site(s) to the homeodo-
main region of Dlx3. Interestingly, the amino-terminal dele-
tion mutant Dlx3 (124^287) and homeodomain (130^188)
were more strongly phosphorylated by PKC than full-length
Dlx3. Analysis of the amino acid sequence in the homeodo-
main region indicated three serine residues (Ser137, Ser138, and
Ser182) and three threonine residues as potential candidates for
phosphorylation sites (Fig. 3A). Before the determination of
the speci¢c phosphorylation site(s), we performed mass spec-
trometry for analysis of the molecular weight of proteolytic
peptides comparing the wild type and phosphorylated homeo-
domains of Dlx3 (Fig. 3B). We found that for the peptide
containing amino acids of the phosphorylated form valued
by 80 (approx. MW of phosphate) when compared to the
non-phosphorylated corresponding peptide (134^146: TIYS-
SYQLAALQR; MW 1513) (Fig. 3B, right panel, arrow indi-
cated). Peak heights shown in Fig. 3B do not re£ect relative
amounts. As mass spectra are recorded in the positive mode,
the introduction of a negative group by phosphorylation is
expected greatly to reduce the peak height at m/z 1593. This
result suggested that one of the serine residues (S137, S138) or
the threonine residue (T134) was phosphorylated in this region.
Since trypsin cuts the peptide bond after an Arg or Lys res-
idue, the potential phosphorylation of residue S182 could not
be assessed by mass spectrometry. Therefore, we tested all
three serine residues (S137, S138, S182) with in vitro mutagenesis
analysis. In vitro mutagenesis was performed, in which each
potential phosphorylation site including S182 residue was re-
placed with an alanine. Of the three serine residue mutant
Dlx3 proteins, Dlx3S137A was phosphorylated, whereas
Dlx3S138A and Dlx3S182A were phosphorylated weakly or not
at all (Fig. 3C, left panel). We also tested one threonine res-
idue (T134) and the double serine residue mutant Dlx3S137;138A.
Dlx3T134A was phosphorylated while Dlx3S137;138A was not
phosphorylated (Fig. 3C, right panel). These results support
that the S138 residue in the Dlx3 protein homeobox region was
the primary site of phosphorylation by PKC.
To determine whether phosphorylation of Dlx3 protein
could a¡ect the functions of Dlx3 as a transcriptional activa-
tor, we tested the DNA binding a⁄nities of the phosphory-
lated and non-phosphorylated forms of Dlx3 by gel retarda-
tion assay using the consensus Dlx3 binding site
(ATAATTGC) [5]. We prepared GST-Dlx3 fusion protein
and incubated it in the presence or absence of PKCK. Gel
retardation assays were performed with phosphorylated and
non-phosphorylated GST-Dlx3 fusion proteins. The amounts
of protein used in this assay were approximately equivalent to
50, 100, and 200 ng in lanes 1, 2, and 3 for the non-phosphor-
ylated form and lanes 5, 6, and 7 for the phosphorylated
form. As shown in Fig. 4A, the intensity of the complexes
formed with phosphorylated Dlx3 was decreased when com-
pared to that of the non-phosphorylated form. The shifted
bands were scanned and plotted against protein concentration
(Fig. 4B). Phosphorylation of Dlx3 shifted the plotted line
downward. These results suggest that the phosphorylated
Dlx3 had lower DNA binding a⁄nity than the non-phosphor-
ylated protein.
Fig. 2. Phosphorylation by PKC within the homeodomain of Dlx3.
A: Schematic representation of Dlx3 deletions. B: In vitro PKC
phosphorylation of Dlx3 proteins described in A. Each mutant pro-
tein was incubated with Q-ATP in the presence or absence of PKC.
Each sample was subjected to SDS^PAGE and transferred to a
PVDF membrane. The upper panel shows the results of autoradiog-
raphy. The amount of each protein is shown in the bottom panel
by Western blot.
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4. Discussion
The Dlx3 gene is expressed in the suprabasal layer of skin.
Dlx3 expression is dramatically increased in cultured primary
mouse keratinocytes induced to di¡erentiate by extracellular
calcium. Since PKC activation is required for keratinocyte
di¡erentiation, we hypothesized that there is a relationship
between regulation of Dlx3 protein and the PKC signaling
pathway in this process. In this study, we present evidence
that the Dlx3 protein is a substrate of PKC in vitro, and
that phosphorylation of Dlx3 modulates its DNA binding.
Dlx3 protein is phosphorylated with nuclear extracts of mouse
keratinocytes and this phosphorylation is inhibited by the
PKC inhibitor GF109203X, which suggests that Dlx3 protein
is phosphorylated by PKC in vivo. Delineation of the phos-
phorylation site(s) of Dlx3 was examined by in vitro phos-
phorylation using truncated Dlx3 mutant proteins. We have
also shown that Dlx3 protein is phosphorylated in vitro pri-
marily by puri¢ed PKCK. Nishikawa et al. [20] determined the
optimal peptide substrate sequence for nine of the PKC iso-
forms. PKCK selected peptides with basic amino acids at po-
sitions 37, 36, 34, and 32. At position 35, PKCK strongly
selected peptides with Arg at this position and preferred pep-
tides with Ala or Lys at the +5 position. The sequence around
S138 has an Arg at 35 and Ala at +5 and basic amino acids at
the amino-terminal of S138, while S137 and S182 have a Phe at
Fig. 3. Determination of the PKC phosphorylation site in the homeodomain of Dlx3. A: Schematic representation of the amino acids in the
homeodomain region (underlined). Three serine residues and three threonine residues are in this homeodomain region. B: Spectra from mass
spectrometry analysis of non-phosphopeptide (left panel) and phosphopeptide (right panel) of the Dlx3 homeodomain region (phosphorylated
by PKC in vitro). The numbers on each peak represent the molecular weight of each proteolytic peptide. The sequence of each peptide was
identi¢ed based on the molecular weight. The arrow indicates the new peak that by MW corresponds to the 1513.80 peak plus the phosphate
group. C: Each mutant Dlx3 protein was incubated with Q-ATP in the presence or absence of PKC. Each sample was subjected to SDS^PAGE
and transferred to a PVDF membrane. The upper panel presents the results of autoradiography. The amount of protein in each reaction was
analyzed by Western blotting (lower panel).
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position 35. Based on the report by Nishikawa et al., the S138
residue is a relatively good substrate for PKCK by sequence
comparison. In addition to PKCK, PKCR has been strongly
associated with keratinocyte di¡erentiation [21]. However, we
were not able to evaluate the ability of PKCR to phosphory-
late Dlx3. Thus, we cannot rule out the possibility that PKCR
can phosphorylate Dlx3 and may also regulate its function.
Future studies will address this possibility.
As has recently been shown for other homeodomain pro-
teins [22,23], Dlx3 protein is phosphorylated within the ho-
meodomain region. Interestingly, the full-length Dlx3 protein
was phosphorylated to a much lesser extent than the N-ter-
minal deletion. Our data indicate that the N-terminal region
of Dlx3 in some way interferes with the phosphorylation in
the homeodomain, possibly due to three-dimensional confor-
mation. However, when the full-length Dlx3 protein was
phosphorylated by PKC, a decreased DNA binding activity
was observed.
The process of cellular di¡erentiation partly results from
di¡erential gene expression regulated through speci¢c func-
tions of transcription factors, and the function is dependent
on nuclear localization, DNA binding and transactivating
properties. Recently, we have reported that the Dlx3 protein
has a nuclear localization signal (NLS) located in the N-ter-
minal region of the homeodomain [18]. The delineated Dlx3
bipartite NLS is necessary not only for intracellular localiza-
tion but also for transcriptional activity, protein:protein in-
teraction and DNA binding. Homeodomain proteins direct
DNA binding through the homeodomain region, where the
N-terminal arm of the homeodomain is oriented such that it
inserts into the minor groove of the DNA. The Dlx3 bipartite
NLS and the speci¢c phosphorylation site for PKC deter-
mined in this study lie within the N-terminal arm. Altogether,
these results suggest that modi¢cations such as phosphoryla-
tion within the NLS might a¡ect the ability of Dlx3 to bind
DNA (TAATT consensus motif) by interfering with minor
groove DNA recognition and binding. A recent report has
shown that phosphorylation of the homeodomain protein
Csx/Nkx2.5 by CKII increased the DNA binding a⁄nity
[22]. Therefore, by phosphorylation, homeodomain protein
function can be modulated positively or negatively. Our ¢nd-
ings suggest that the function of Dlx3 protein is modulated in
vitro by PKC phosphorylation.
From the PKC isoforms expressed in epidermis (K, N, O, R,
j), the isoforms N, O, and R are involved in the regulation of
human involucrin gene expression [15]. PKCK is an important
component of the signaling pathway regulating terminal dif-
ferentiation of keratinocytes [24]. In our results, Dlx3 protein
was phosphorylated primarily by PKCK and this modi¢cation
reduced the DNA binding. We have evidence that PKC in-
hibitors repress the transcription of the Dlx3 gene upon di¡er-
entiation [25]. Therefore, Dlx3 gene expression and function
in the keratinocytes is hypothetically under both positive and
negative regulation by PKC.
Since DNA binding may reveal only a part of Dlx3 protein
function, we cannot rule out the in£uence of phosphorylation
on other biological functions. Thus, the characterization of
the full biological function of PKC phosphorylation of Dlx3
protein will require further studies.
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